Cases 11 - 20 of 26
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00037
Plaintiff:
Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2019cv08233
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC et al
as 1:2018cv01586
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Fresenius Kabi USA, LLC and Mylan Laboratories Ltd.
Cause Of Action: 28 U.S.C. § 2201
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00184
Plaintiff:
Kaken Pharmaceutical Co. Ltd., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2018cv14305
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv01671
Plaintiff:
ViiV Healthcare Company , Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
VIIV Healthcare Company et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2017cv00197
Plaintiff:
VIIV Healthcare Company , Shionogi & Co., LTD., and VIIV Healthcare UK (No. 3) Limited
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al
as 2:2017cv06714
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. , SALIX PHARMACEUTICALS, INC. , PROGENICS PHARMACEUTICALS, INC. and others
Defendant:
MYLAN PHARAMACEUTICALS, INC., MYLAN LABORATORIES LTD. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
Mallinckrodt IP v. Mylan Laboratories Ltd. et al
as 1:2016cv01115
Plaintiff:
Mallinckrodt IP
Defendant:
Mylan Laboratories Ltd. and Agila Specialties Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2016cv00035
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. , SALIX PHARMACEUTICALS, INC. , PROGENICS PHARMACEUTICALS, INC. and others
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN LABORATORIES LTD. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
